(Q43813704)

27 November 2017

title

Osteoporosis prescribing trends in primary care: a population-based retrospective cohort study (English)

1 reference

27 November 2017

0 references

4

1 reference

27 November 2017

Li Wang

1

1 reference

27 November 2017

C Shawn Tracy

series ordinal

2

1 reference

27 November 2017

Rahim Moineddin

series ordinal

3

1 reference

27 November 2017

publication date

23 April 2012

1 reference

Primary Health Care Research and Development

27 November 2017

published in

1 reference

27 November 2017

volume

14

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

1-6

1 reference

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Secondary prevention of osteoporosis in Australia: analysis of government-dispensed prescription data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Management of osteoporosis in primary care in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Living with a `women's disease': risk appraisal and management among men with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

Opinions and Experiences in General Practice on Osteoporosis Prevention, Diagnosis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

7 January 2021

Osteoporosis in males and females: Is there really a difference?

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

7 January 2021

Hip fracture incidence rates in Singapore 1991-1998

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

7 January 2021

Transmission of human herpesvirus 8 by blood transfusion

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

7 January 2021

To stop or not to stop, that is the question

1 reference

https://api.crossref.org/works/10.1017%2FS1463423612000114

7 January 2021

10.1017/S1463423612000114

Identifiers

DOI

1 reference

27 November 2017

1 reference